World first for AI and machine learning to treat COVID-19 patients worldwide

Four Cambridge researchers recognised in the 2022 Breakthrough Prizes

Spread of Delta SARS-CoV-2 variant driven by combination of immune escape and increased infectivity

Patients with SARS-CoV-2 Delta variant were more likely to be admitted to hospital compared to patients with Alpha variant

Discovery of origin of oesophageal cancer cells highlights importance of screening for pre-cancerous Barrett’s oesophagus

The virologist helping us to stay one step ahead of infectious diseases

Lab-grown beating heart cells identify potential drug to prevent COVID-19-related heart damage

Rare genetic variants confer largest increase in type 2 diabetes risk seen to date

Scientists identify 160 new drugs that could be repurposed against COVID-19

Upgrading PPE for staff working on COVID-19 wards cut hospital-acquired infections dramatically

Targeting cellular response to SARS-CoV-2 holds promise as new way to fight infection

How mass testing helped limit the spread of COVID-19 at the University of Cambridge.